439 related articles for article (PubMed ID: 9822164)
1. Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes.
Lombardi VR; García M; Cacabelos R
J Neurosci Res; 1998 Nov; 54(4):539-53. PubMed ID: 9822164
[TBL] [Abstract][Full Text] [Related]
2. APOE-induced microglial activation: an in vitro assay to screen sera from Alzheimer's disease patients and novel therapeutic compounds.
Lombardi VR; García M; Cacabelow R
Methods Find Exp Clin Pharmacol; 1998 Jun; 20(5):377-86. PubMed ID: 9701775
[TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner.
Wong MY; Lewis M; Doherty JJ; Shi Y; Cashikar AG; Amelianchik A; Tymchuk S; Sullivan PM; Qian M; Covey DF; Petsko GA; Holtzman DM; Paul SM; Luo W
J Neuroinflammation; 2020 Jun; 17(1):192. PubMed ID: 32552741
[TBL] [Abstract][Full Text] [Related]
4. Microglial activation in Alzheimer disease: Association with APOE genotype.
Egensperger R; Kösel S; von Eitzen U; Graeber MB
Brain Pathol; 1998 Jul; 8(3):439-47. PubMed ID: 9669695
[TBL] [Abstract][Full Text] [Related]
5. Neuronal Regulation of Neuroprotective Microglial Apolipoprotein E Secretion in Rat In Vitro Models of Brain Pathophysiology.
Polazzi E; Mengoni I; Peña-Altamira E; Massenzio F; Virgili M; Petralla S; Monti B
J Neuropathol Exp Neurol; 2015 Aug; 74(8):818-34. PubMed ID: 26185969
[TBL] [Abstract][Full Text] [Related]
6. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
7. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.
Reynolds WF; Rhees J; Maciejewski D; Paladino T; Sieburg H; Maki RA; Masliah E
Exp Neurol; 1999 Jan; 155(1):31-41. PubMed ID: 9918702
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E deficiency increased microglial activation/CCR3 expression and hippocampal damage in kainic acid exposed mice.
Duan RS; Chen Z; Dou YC; Concha Quezada H; Nennesmo I; Adem A; Winblad B; Zhu J
Exp Neurol; 2006 Dec; 202(2):373-80. PubMed ID: 16919271
[TBL] [Abstract][Full Text] [Related]
10. A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer's disease.
Hayes A; Green EK; Pritchard A; Harris JM; Zhang Y; Lambert JC; Chartier-Harlin MC; Pickering-Brown SM; Lendon CL; Mann DM
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1475-7. PubMed ID: 15377701
[TBL] [Abstract][Full Text] [Related]
11. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
14. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma and LPS-mediated IL-10-dependent suppression of retinal microglial activation.
Broderick C; Duncan L; Taylor N; Dick AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2613-22. PubMed ID: 10937574
[TBL] [Abstract][Full Text] [Related]
16. Activated microglia do not mediate the early deposition of Abeta in carriers of the apolipoprotein Eepsilon4 allele.
Vogelgesang S; Schroeder E; Walker LC; Pahnke J; Naubereit A; Walther R; Stausske D; Warzok RW
Clin Neuropathol; 2002; 21(3):99-106. PubMed ID: 12049183
[TBL] [Abstract][Full Text] [Related]
17. Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide.
Saura J; Petegnief V; Wu X; Liang Y; Paul SM
J Neurochem; 2003 Jun; 85(6):1455-67. PubMed ID: 12787065
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
19. Effects of high cholesterol diet on gliosis in apolipoprotein E knockout mice. Implications for Alzheimer's disease and stroke.
Crisby M; Rahman SM; Sylvén C; Winblad B; Schultzberg M
Neurosci Lett; 2004 Oct; 369(2):87-92. PubMed ID: 15450674
[TBL] [Abstract][Full Text] [Related]
20. Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production.
Laskowitz DT; Matthew WD; Bennett ER; Schmechel D; Herbstreith MH; Goel S; McMillian MK
Neuroreport; 1998 Mar; 9(4):615-8. PubMed ID: 9559926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
